Pharmaceutical, BioTech Product Launches and Technology Innovations

ChromaDex Corp. the global authority on nicotinamide adenine dinucleotide (NAD+) and healthy aging research, launched its flagship consumer supplement, Tru Niagen®,

StatLab Medical Products (“StatLab”), a leading developer and manufacturer of medical diagnostic supplies and equipment,announced the acquisition of Scientific Device Laboratory (“SDL”), a Chicago-based manufacturer of printed diagnostic slides and a variety of consumables and kits for the anatomic pathology and microbiology markets.

Cellares, the first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, unveiled Cell Q™, the first automated quality control (QC) workcell for cell therapy manufacturing. Cell Q™ addresses a critical challenge.

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, it has launched Desmopressin Acetate for Injection in the United States as a therapeutic equivalent generic for DDAVP® for Injection (Desmopressin Acetate) approved by the U.S.

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, it has launched Fosaprepitant for Injection and Fulvestrant Injection in the United States.